NDRA ENDRA Life Sciences Inc
Price (delayed)
$4.09
Market cap
$2.3M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$56.94
Enterprise value
$453,674
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the
Highlights
The company's EPS has surged by 98% YoY and by 92% QoQ
The company's quick ratio has surged by 70% YoY but it fell by 8% QoQ
NDRA's equity has dropped by 61% since the previous quarter and by 55% year-on-year
ENDRA Life Sciences's net income has decreased by 30% from the previous quarter and by 14% YoY
Key stats
What are the main financial stats of NDRA
Market
Valuations
Earnings
Shares outstanding
562,213
Market cap
$2.3M
Enterprise value
$453,674
Price to earnings (P/E)
N/A
Price to book (P/B)
0.86
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$10.82M
Net income
-$11.51M
EBIT
-$11.51M
EBITDA
-$11.3M
Free cash flow
-$7.41M
Per share
Balance sheet
Liquidity
EPS
-$56.94
EPS diluted
-$56.94
Free cash flow per share
-$36.68
Book value per share
$4.77
Revenue per share
$0
TBVPS
$22.03
Total assets
$4.45M
Total liabilities
$1.89M
Debt
$1.38M
Equity
$2.56M
Working capital
$2.83M
Debt to equity
0.54
Current ratio
5.67
Quick ratio
5.34
Net debt/EBITDA
0.16
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-162.5%
Return on equity
-210.6%
Return on invested capital
-384.4%
Return on capital employed
-299.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NDRA stock price
How has the ENDRA Life Sciences stock price performed over time
Intraday
4.34%
1 week
-2.14%
1 month
-5.54%
1 year
-99.36%
YTD
-34.66%
QTD
-0.24%
Financial performance
How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.82M
Net income
-$11.51M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 43% since the previous quarter and by 2.8% year-on-year
ENDRA Life Sciences's net income has decreased by 30% from the previous quarter and by 14% YoY
Growth
What is ENDRA Life Sciences's growth rate over time
Valuation
What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
0.86
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 98% YoY and by 92% QoQ
NDRA's P/B is 74% less than its 5-year quarterly average of 3.1 but 2.5% more than its last 4 quarters average of 0.8
NDRA's equity has dropped by 61% since the previous quarter and by 55% year-on-year
Efficiency
How efficient is ENDRA Life Sciences business performance
The return on equity has declined by 49% since the previous quarter and by 17% year-on-year
The company's return on invested capital fell by 46% QoQ and by 13% YoY
The ROA has declined by 41% since the previous quarter and by 22% year-on-year
Dividends
What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NDRA.
Financial health
How did ENDRA Life Sciences financials performed over time
NDRA's total assets is 135% greater than its total liabilities
The total liabilities has surged by 73% year-on-year and by 7% since the previous quarter
The company's quick ratio has surged by 70% YoY but it fell by 8% QoQ
The debt is 46% less than the equity
NDRA's equity has dropped by 61% since the previous quarter and by 55% year-on-year
The debt has increased by 21% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.